IDL Diagnostics AB (publ) (STO:IDLDX)

IDL Diagnostics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	37.33	36.57	47.79	50.72	65.19	18.4
Cash & Short-Term Investments	37.33	36.57	47.79	50.72	65.19	18.4
Cash Growth	-19.66%	-23.46%	-5.79%	-22.19%	254.25%	-56.25%
Accounts Receivable	8.5	10.83	10.32	6.08	7.12	2.72
Other Receivables	1.2	2.56	2.44	1.36	3.14	2.99
Receivables	9.69	13.39	12.75	7.44	10.25	5.7
Inventory	7.61	6.69	5.73	6.07	7.38	6.91
Prepaid Expenses	1.15	0.08	0.05	0.86	0.53	0.61
Other Current Assets	0	0	-0	0	0	0
Total Current Assets	55.79	56.73	66.31	65.1	83.35	31.63
Property, Plant & Equipment	14.37	14.9	17.42	2.74	3.32	1.16
Goodwill	98.99	98.99	98.99	98.99	138.57	178.15
Other Intangible Assets	6.63	0.57	0.85	1.24	0.31	0.51
Long-Term Deferred Charges	-	5.68	4.96	6.82	10.47	15.97
Other Long-Term Assets	0.05	-0	0	-	0	0
Total Assets	175.83	176.86	188.53	174.89	236.01	227.42

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.21	5.76	4.21	3.21	6.12	3.39
Accrued Expenses	8.01	7.2	7.62	5.34	4.32	3.68
Current Portion of Leases	2.23	2.2	2.06	-	-	-
Current Unearned Revenue	-	0.22	-	-	-	-
Other Current Liabilities	1.55	2.29	1.1	2.69	2.87	2.89
Total Current Liabilities	15.99	17.67	14.99	11.25	13.32	9.96
Long-Term Leases	10.46	11.04	13.24	-	-	-
Other Long-Term Liabilities	0.01	-	-	-	-	0
Total Liabilities	26.46	28.71	28.22	11.25	13.32	9.96

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	149.37	23.04	23.04	23.04	23.04	11.46
Additional Paid-In Capital	-	441.01	441.01	441.01	440.76	376.73
Retained Earnings	-	-315.89	-303.74	-300.4	-241.1	-174.67
Comprehensive Income & Other	-	-	0	-	0	0
Total Common Equity	149.37	148.16	160.31	163.65	222.69	213.52
Minority Interest	-	-	-	-	-	3.93
Shareholders' Equity	149.37	148.16	160.31	163.65	222.69	217.45
Total Liabilities & Equity	175.83	176.86	188.53	174.89	236.01	227.42

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.69	13.24	15.3	-	-	-
Net Cash (Debt)	24.65	23.34	32.49	50.72	65.19	18.4
Net Cash Growth	-46.97%	-28.17%	-35.95%	-22.19%	254.25%	-56.25%
Net Cash Per Share	0.11	0.10	0.14	0.22	0.30	0.20
Filing Date Shares Outstanding	230.36	230.36	230.36	230.36	230.36	114.61
Total Common Shares Outstanding	230.36	230.36	230.36	230.36	230.36	114.61
Working Capital	39.8	39.06	51.32	53.85	70.03	21.67
Book Value Per Share	0.65	0.64	0.70	0.71	0.97	1.86
Tangible Book Value	43.75	48.6	60.46	63.42	83.82	34.86
Tangible Book Value Per Share	0.19	0.21	0.26	0.28	0.36	0.30
Machinery	-	7.71	7.04	6.89	6.48	3.6

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error